Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finkel

Showing results (161-170 of 289) with videos related to

Pageof 29
Sort By:
Emerging Infectious Diseases|July 27, 2002
Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000Alice Y Ho, Adriana S Lopez, Michael G Eberhart, et al.
Muscle & Nerve|July 30, 2013
The motor neuron response to SMN1 deficiency in spinal muscular atrophyPeter B Kang, Clifton L Gooch, Michael P McDermott, et al.
Annals of Clinical and Translational Neurology|May 14, 2022
Scientific rationale for a higher dose of nusinersenRichard S Finkel, Monique M Ryan, Samuel Ignacio Pascual Pascual, et al.
Annals of Neurology|April 24, 2012
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disabilityJoshua Burns, Robert Ouvrier, Tim Estilow, et al.
Orphanet Journal of Rare Diseases|April 7, 2020
Longitudinal natural history of type I spinal muscular atrophy: a critical reviewEugenio Mercuri, Simona Lucibello, Marco Perulli, et al.
Lancet (London, England)|April 25, 2015
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trialGunnar M Buyse, Thomas Voit, Ulrike Schara, et al.
Plos Pathogens|February 24, 2012
Portrait of Candida albicans adherence regulatorsJonathan S Finkel, Wenjie Xu, David Huang, et al.
Neurology|April 5, 2013
Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrumDiana Xerxes Bharucha-Goebel, Mariarita Santi, Livija Medne, et al.
Journal of the Peripheral Nervous System : JPNS|June 21, 2013
Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth diseaseJoshua Burns, Manoj Menezes, Richard S Finkel, et al.
The Journal of Clinical Investigation|September 16, 2025
Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophyCrystal M Proud, Richard S Finkel, Julie A Parsons, et al.
Pageof 29

Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
Emerging Infectious Diseases|July 27, 2002
Outbreak of cyclosporiasis associated with imported raspberries, Philadelphia, Pennsylvania, 2000Alice Y Ho, Adriana S Lopez, Michael G Eberhart, et al.
Muscle & Nerve|July 30, 2013
The motor neuron response to SMN1 deficiency in spinal muscular atrophyPeter B Kang, Clifton L Gooch, Michael P McDermott, et al.
Annals of Clinical and Translational Neurology|May 14, 2022
Scientific rationale for a higher dose of nusinersenRichard S Finkel, Monique M Ryan, Samuel Ignacio Pascual Pascual, et al.
Annals of Neurology|April 24, 2012
Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disabilityJoshua Burns, Robert Ouvrier, Tim Estilow, et al.
Orphanet Journal of Rare Diseases|April 7, 2020
Longitudinal natural history of type I spinal muscular atrophy: a critical reviewEugenio Mercuri, Simona Lucibello, Marco Perulli, et al.
Lancet (London, England)|April 25, 2015
Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trialGunnar M Buyse, Thomas Voit, Ulrike Schara, et al.
Plos Pathogens|February 24, 2012
Portrait of Candida albicans adherence regulatorsJonathan S Finkel, Wenjie Xu, David Huang, et al.
Neurology|April 5, 2013
Severe congenital RYR1-associated myopathy: the expanding clinicopathologic and genetic spectrumDiana Xerxes Bharucha-Goebel, Mariarita Santi, Livija Medne, et al.
Journal of the Peripheral Nervous System : JPNS|June 21, 2013
Transitioning outcome measures: relationship between the CMTPedS and CMTNSv2 in children, adolescents, and young adults with Charcot-Marie-Tooth diseaseJoshua Burns, Manoj Menezes, Richard S Finkel, et al.
The Journal of Clinical Investigation|September 16, 2025
Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophyCrystal M Proud, Richard S Finkel, Julie A Parsons, et al.
Pageof 29